Literature DB >> 7648985

Glucagon, stress, and portal hypertension. Plasma glucagon levels and portal hypertension in relation to anesthesia and surgical stress.

T J Johnson1, E M Quigley, T E Adrian, G Jin, L F Rikkers.   

Abstract

Glucagon has been proposed as the mediator of splanchnic hyperemia in portal hypertension. Employing an assay specific for pancreatic glucagon, we reevaluated the relationship between this peptide and portal hypertension in the portal vein (PV)-stenosed rat model addressing, in particular, the effects of anesthesia and surgical stress. Plasma glucagon levels were similar in sham-operated and portal hypertensive rats: glucagon, sham vs PV stenosed: 110.7 +/- 17.1 pmol/liter vs 140.6 +/- 23.3 pmol/liter (NS). Furthermore, plasma levels of glucagon and the related peptide VIP were not significantly influenced by anesthesia or surgical stress, and levels remained similar under all conditions in sham-operated and PV-stenosed animals. We conclude that pancreatic glucagon is not elevated in the PV-stenosed rat; differences between these results and those describing hyperglucagonemia in this model cannot be explained on the basis of a differential response to stress but may reflect differences in glucagon assay system.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7648985     DOI: 10.1007/bf02212707

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  31 in total

1.  Glucagon antibodies and an immunoassay for glucagon.

Authors:  R H UNGER; A M EISENTRAUT; M S McCALL; L L MADISON
Journal:  J Clin Invest       Date:  1961-07       Impact factor: 14.808

2.  Production and characterization of an antiserum against pancreatic glucagon.

Authors:  H Von Schenck
Journal:  Clin Chim Acta       Date:  1977-11-01       Impact factor: 3.786

Review 3.  Splanchnic hemodynamics in chronic portal hypertension.

Authors:  J N Benoit; D N Granger
Journal:  Semin Liver Dis       Date:  1986-11       Impact factor: 6.115

4.  Intestinal and pancreatic glucagon-like peptides. Evidence for identity of higher molecular weight forms.

Authors:  H S Tager; J Markese
Journal:  J Biol Chem       Date:  1979-04-10       Impact factor: 5.157

5.  Intestinal microvascular responsiveness to norepinephrine in chronic portal hypertension.

Authors:  T Joh; D N Granger; J N Benoit
Journal:  Am J Physiol       Date:  1991-04

6.  Plasma endothelin levels in cirrhotic subjects.

Authors:  F Veglio; G Pinna; R Melchio; F Rabbia; M Panarelli; B Gagliardi; L Chiandussi
Journal:  J Hepatol       Date:  1992-05       Impact factor: 25.083

7.  Hyperglucagonemia in cirrhosis: altered secretion and sensitivity to glucagon.

Authors:  R S Sherwin; M Fisher; J Bessoff; N Snyder; R Hendler; H O Conn; P Felig
Journal:  Gastroenterology       Date:  1978-06       Impact factor: 22.682

8.  Role of bile acids in splanchnic hemodynamic response to chronic portal hypertension.

Authors:  S H Thomas; T Joh; J N Benoit
Journal:  Dig Dis Sci       Date:  1991-09       Impact factor: 3.199

9.  Role of prostacyclin in the splanchnic hyperemia contributing to portal hypertension.

Authors:  J V Sitzmann; G B Bulkley; M C Mitchell; K Campbell
Journal:  Ann Surg       Date:  1989-03       Impact factor: 12.969

10.  Measurement of portal-systemic shunting in the rat by using gamma-labeled microspheres.

Authors:  M Chojkier; R J Groszmann
Journal:  Am J Physiol       Date:  1981-05
View more
  4 in total

Review 1.  Gastrointestinal dysfunction in liver disease and portal hypertension. Gut-liver interactions revisited.

Authors:  E M Quigley
Journal:  Dig Dis Sci       Date:  1996-03       Impact factor: 3.199

2.  Altered small bowel motility in patients with liver cirrhosis depends on severity of liver disease.

Authors:  A M Madrid; F Cumsille; C Defilippi
Journal:  Dig Dis Sci       Date:  1997-04       Impact factor: 3.199

3.  Effects of transmitters and interleukin-10 on rat hepatic fibrosis induced by CCl4.

Authors:  Xiao-Zhong Wang; Li-Juan Zhang; Dan Li; Yue-Hong Huang; Zhi-Xin Chen; Bin Li
Journal:  World J Gastroenterol       Date:  2003-03       Impact factor: 5.742

4.  Pressure suppresses hepatocellular glycogen synthesis through activating the p53/Pten pathway.

Authors:  Junwei Shen; Yunchen Sun; Si Shen; Xu Luo; Jie Chen; Liang Zhu
Journal:  Mol Med Rep       Date:  2019-04-19       Impact factor: 2.952

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.